Dr. Alvaro Ryes, MD

• Nephrology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• San Juan De Dios University Nacional De Colombia

  Residency Hospital

• St Luke's Hospital

  1996

• Barnes Hosp/wvmc

  Fellowship Hospital, 1991

• Washington University School Of Medicine

  Fellowship Hospital, 1991

• Hsjd

  Residency Hospital, 1988

• Barnes Hosp/washington University Medical School

  Fellowship Hospital, 1988

• Universidad Nacional De Colombia, Facultad De Medicina

  Medical School, 1982

• University Natl De Colombia, Bogota

  Medical School, 1982

• Hmc

  Internship Hospital, 1982

• English

• Spanish

• Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction. Proc Soc Exp Biol Med 1991: 198: 572-578.

• EDRF role in renal function and blood pressure of normal rats and rats with obstructive nephropathy. Kidney Int 1992; 41:403-413.

• A high cholesterol diet ameliorates renal tubular lesions in diabetic rats. Proc Soc Exp Biol Med 1990;194:185-194.

• Role of vasopressin in rats with bilateral ureteral obstruction. Pro Soc Exp Biol Med 1991;197:49-55.

• L-arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 1993;4:1039-1045.

• Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral obstruction. Kidney Int 1995;47:1285-1294.

• Recombinant human erythropoietin (rHuEPO) stimulates angiogenesis in vitro. Kidney Int 1995;47:740-745.

• Administration of L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 1994;45:1346-1354.

• Osteopontin expression in kidney during unilateral ureteral obstruction. Miner Electrolyte Metab 1998;24:227-237.

• Dietary supplements with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 1994;4:1690-1694.

• Renal function after release of ureteral obstruction: Role of endothelin and the renal artery endothelium. Kidney Int 1992;42:632-638.

• Role of arginine in health and in renal disease (Editorial). Am J Physiol (Renal, Fluids and Electrolytes) 1994:267:F331-F346.

• Dietary supplementation of L-arginine ameliorates hypertrophy in rats feed high protein diet. Proc Soc Exp Biol Med 1994:45:157-161.

• Role of the 5-Lipooxygenase pathway in obstructive nephropathy. Kidney Int 1992:100-106.

• Bladder contributes to eicosanoids excreted in urine. Am J Physiol 1990;258:F859-F861.

• Subdiaphragmatic vagotomy in rats induces hypertension and sodium retention. J Miner Metab 1992;18:375-381.

• The cytochrome p-450 pathway in renal function of normal rats and rats with bilateral ureteral obstruction. Pro Soc Exp Biol Med 1992;201:278-283.

• Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992:20:168-176.

• Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed kidney of the rat. Kidney Int 1994;45:1637-1647.

• Low plasma and renal tissue levels of L-arginine in rats with obstructive nephropathy. Kidney Int 1994;45:782-787.

• : Role of platelet-activating factor in renal function in normal rats and rats with bilateral ureteral obstruction. Proc Soc Exp Biol Med 1991: 198: 572-578.